Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE: Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc. 2003, 9: 967-982.
Article
PubMed
Google Scholar
Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J: A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer. 2005, 104: 2222-2233. 10.1002/cncr.21469.
Article
PubMed
Google Scholar
Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E: A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol. 2006, 20: 76-89. 10.1080/138540491005875.
Article
PubMed
Google Scholar
Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips K-A: The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn. 2005, 59: 60-70. 10.1016/j.bandc.2005.05.001.
Article
PubMed
Google Scholar
Wefel JS, Vardy J, Ahles T, Schagen SB: International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011, 12: 703-708. 10.1016/S1470-2045(10)70294-1.
Article
PubMed
Google Scholar
Wefel JS, Witgert ME, Meyers CA: Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev. 2008, 18: 121-131. 10.1007/s11065-008-9058-x.
Article
PubMed
Google Scholar
Correa DD, Ahles TA: Neurocognitive changes in cancer survivors. Cancer J. 2008, 14: 396-400. 10.1097/PPO.0b013e31818d8769.
Article
PubMed
Google Scholar
McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ: Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res Treat. 2010, 123: 819-828. 10.1007/s10549-010-1088-4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Inagaki M, Yoshikawa E, Matsuoka Y, Sugawara Y, Nakano T, Akechi T, Wada N, Imoto S, Murakami K, Uchitomi Y: Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer. 2007, 109: 146-156. 10.1002/cncr.22368.
Article
PubMed
Google Scholar
Ahles TA, Saykin AJ, Noll WW, Furstenberg CT, Guerin S, Cole B, Mott LA: The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology. 2003, 12: 612-619. 10.1002/pon.742.
Article
PubMed
Google Scholar
Ahles TA, Saykin AJ: Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer. 2007, 7: 192-201. 10.1038/nrc2073.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB: Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol. 2008, 19: 623-629.
Article
CAS
PubMed
Google Scholar
Vardy J, Rourke S, Tannock IF: Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol. 2007, 25: 2455-2463. 10.1200/JCO.2006.08.1604.
Article
PubMed
Google Scholar
Tannock IF, Ahles TA, Ganz PA, Van Dam FS: Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol. 2004, 22: 2233-2239. 10.1200/JCO.2004.08.094.
Article
PubMed
Google Scholar
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H: The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005, 53: 695-699. 10.1111/j.1532-5415.2005.53221.x.
Article
PubMed
Google Scholar
Van Der Linden M, Coyette F, Pitrenaud J, GREMEM M: L’épreuve de rappel libre/rappel indicé à 16 items (RL/RI-16). L’évaluation des troubles de la mémoire. Edited by: Van Der Linden M, Adam S, Agniel A, GREMEM M. 2004, Marseille: Présentation de quatre tests de mémoire épisodique (avec leur étalonnage), 25-47.
Google Scholar
Grober E, Buschke H: Guenine memory deficits in dementia. Dev Neuropsychol. 1987, 3: 13-36. 10.1080/87565648709540361.
Article
Google Scholar
Folstein MF, Folstein SE, McHugh PR: « Mini-mental state ». A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975, 12: 189-198. 10.1016/0022-3956(75)90026-6.
Article
CAS
PubMed
Google Scholar
Mattis S: Mental status examination for organic mental syndrome in the elderly patients. Geriatric psychiatry: a handbook for psychiatrists and primary care physicians. Edited by: Bellak L, Karasu T. 1973, New York: Grune and Stratton, 77-101.
Google Scholar
Dimopoulos M, Spencer A, Attal M, Prince HM, Harousseau J-L, Dmoszynska A, San Miguel J, Hellmann A, Facon T, Foà R, Corso A, Masliak Z, Olesnyckyj M, Yu Z, Patin J, Zeldis JB, Knight RD, Multiple Myeloma (010) Study Investigators: Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma. N Engl J Med. 2007, 357: 2123-2132. 10.1056/NEJMoa070594.
Article
CAS
PubMed
Google Scholar
Weber DM, Chen C, Niesvizky R, Wang M, Belch A, Stadtmauer EA, Siegel D, Borrello I, Rajkumar SV, Chanan-Khan AA, Lonial S, Yu Z, Patin J, Olesnyckyj M, Zeldis JB, Knight RD, Multiple Myeloma (009) Study Investigators: Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America. N Engl J Med. 2007, 357: 2133-2142. 10.1056/NEJMoa070596.
Article
CAS
PubMed
Google Scholar
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30: 239-245. 10.1038/clpt.1981.154.
Article
CAS
PubMed
Google Scholar
Ahles TA, Saykin AJ: Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer. 2002, 3 (Suppl 3): 84-90.
Article
Google Scholar
Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Whedon MB, Bivens S, Mitchell T, Greenberg ER, Silberfarb PM: Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol. 2002, 20: 485-493. 10.1200/JCO.20.2.485.
Article
CAS
PubMed
Google Scholar
Sarazin M, Berr C, De Rotrou J, Fabrigoule C, Pasquier F, Legrain S, Michel B, Puel M, Volteau M, Touchon J, Verny M, Dubois B: Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology. 2007, 69: 1859-1867. 10.1212/01.wnl.0000279336.36610.f7.
Article
CAS
PubMed
Google Scholar
Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P: Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007, 6: 734-746. 10.1016/S1474-4422(07)70178-3.
Article
PubMed
Google Scholar
Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, Münzel K: Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer. 2007, 109: 1905-1913. 10.1002/cncr.22610.
Article
CAS
PubMed
Google Scholar
Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA: The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004, 100: 2292-2299. 10.1002/cncr.20272.
Article
CAS
PubMed
Google Scholar
Quesnel C, Savard J, Ivers H: Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res Treat. 2009, 116: 113-123. 10.1007/s10549-008-0114-2.
Article
PubMed
Google Scholar
Bickeböller H, Campion D, Brice A, Amouyel P, Hannequin D, Didierjean O, Penet C, Martin C, Pérez-Tur J, Michon A, Dubois B, Ledoze F, Thomas-Anterion C, Pasquier F, Puel M, Demonet JF, Moreaud O, Babron MC, Meulien D, Guez D, Chartier-Harlin MC, Frebourg T, Agid Y, Martinez M, Clerget-Darpoux F: Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet. 1997, 60: 439-446.
PubMed
PubMed Central
Google Scholar
Atkins ER, Panegyres PK: The clinical utility of gene testing for Alzheimer’s disease. Neurol Int. 2011, 3: e1-
Article
PubMed
PubMed Central
Google Scholar
Cives M, Milano A, Dammacco F, Silvestris F: Lenalidomide in multiple myeloma: current experimental and clinical data. Eur J Haematol. 2012, 88: 279-291. 10.1111/j.1600-0609.2011.01735.x.
Article
CAS
PubMed
Google Scholar
Rubenstein JL, Treseler PA, Stewart PJ: Regression of refractory intraocular large B-cell lymphoma with lenalidomide monotherapy. J Clin Oncol. 2011, 29: e595-e597. 10.1200/JCO.2011.34.7252.
Article
PubMed
PubMed Central
Google Scholar
Cox MC, Mannino G, Lionetto L, Naso V, Simmaco M, Spiriti MAA: Lenalidomide for aggressive B-cell lymphoma involving the central nervous system?. Am J Hematol. 2011, 86: 957-10.1002/ajh.22148.
Article
PubMed
Google Scholar